Arcus Biosciences Stock Price Prediction
| RCUS Stock | USD 14.70 0.42 2.94% |
Oversold Vs Overbought
59
Oversold | Overbought |
EPS Estimate Next Quarter (1.17) | EPS Estimate Current Year (3.06) | EPS Estimate Next Year (3.64) | Wall Street Target Price 33.2 | EPS Estimate Current Quarter (1.06) |
Using Arcus Biosciences hype-based prediction, you can estimate the value of Arcus Biosciences from the perspective of Arcus Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Arcus Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Arcus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Arcus Biosciences after-hype prediction price | USD 14.52 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Arcus |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Arcus Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Arcus Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Arcus Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Arcus Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Arcus Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Arcus Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Arcus Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Arcus Biosciences' historical news coverage. Arcus Biosciences' after-hype downside and upside margins for the prediction period are 11.10 and 17.94, respectively. We have considered Arcus Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Arcus Biosciences is not too volatile at this time. Analysis and calculation of next after-hype price of Arcus Biosciences is based on 3 months time horizon.
Arcus Biosciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Arcus Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Arcus Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Arcus Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.25 | 3.42 | 0.18 | 0.04 | 10 Events / Month | 3 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
14.70 | 14.52 | 1.22 |
|
Arcus Biosciences Hype Timeline
Arcus Biosciences is at this time traded for 14.70. The entity has historical hype elasticity of -0.18, and average elasticity to hype of competition of 0.04. Arcus is anticipated to decline in value after the next headline, with the price expected to drop to 14.52. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.22%, whereas the daily expected return is at this time at -0.25%. The volatility of related hype on Arcus Biosciences is about 2060.24%, with the expected price after the next announcement by competition of 14.74. About 40.0% of the company outstanding shares are owned by corporate insiders. The book value of Arcus Biosciences was at this time reported as 6.18. The company recorded a loss per share of 3.19. Arcus Biosciences had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 10 days. Check out Arcus Biosciences Basic Forecasting Models to cross-verify your projections.Arcus Biosciences Related Hype Analysis
Having access to credible news sources related to Arcus Biosciences' direct competition is more important than ever and may enhance your ability to predict Arcus Biosciences' future price movements. Getting to know how Arcus Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Arcus Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| LYRA | Lyra Therapeutics | 0.01 | 5 per month | 0.00 | (0.13) | 8.00 | (10.00) | 41.07 | |
| HOOK | Hookipa Pharma | (0.05) | 6 per month | 0.00 | (0.33) | 4.05 | (7.24) | 15.72 | |
| SABS | SAB Biotherapeutics | (0.39) | 8 per month | 6.39 | 0.05 | 17.06 | (11.25) | 45.73 | |
| CVKD | Cadrenal Therapeutics, Common | 1.25 | 10 per month | 6.10 | 0.15 | 17.85 | (7.47) | 47.47 | |
| CHRS | Coherus BioSciences | 0.01 | 9 per month | 4.72 | (0.02) | 7.62 | (6.94) | 26.43 |
Arcus Biosciences Additional Predictive Modules
Most predictive techniques to examine Arcus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Arcus using various technical indicators. When you analyze Arcus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Arcus Biosciences Predictive Indicators
The successful prediction of Arcus Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Arcus Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Arcus Biosciences based on analysis of Arcus Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Arcus Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Arcus Biosciences's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 710.21 | 140.13 | 131.03 | 114.59 | PTB Ratio | 3.34 | 2.27 | 3.06 | 3.39 |
Story Coverage note for Arcus Biosciences
The number of cover stories for Arcus Biosciences depends on current market conditions and Arcus Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Arcus Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Arcus Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Arcus Biosciences Short Properties
Arcus Biosciences' future price predictability will typically decrease when Arcus Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Arcus Biosciences often depends not only on the future outlook of the potential Arcus Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Arcus Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 74 M | |
| Cash And Short Term Investments | 759 M |
Additional Tools for Arcus Stock Analysis
When running Arcus Biosciences' price analysis, check to measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.